Off-label drugs prescribed for breathlessness may do more harm than good, warn scientists
A study from King's College London found that off-label prescriptions of the…
GLP-1 receptor agonists show promise in treating substance use disorders
A systematic review examined the potential of GLP-1 receptor agonists in reducing…
Abnormal HR Shifts Tied to Risk for Death in Diabetes
Impaired circadian heart rate fluctuations in patients with long-standing diabetes are linked…
Top Choices To Support Your Back, Improve Posture
Poor posture can lead to debilitating lower back pain, which affects millions…
Terns Pharma Oral GLP-1 Drug Leads to Greater Than 5% Weight Loss in Small Study
Terns Pharmaceuticals' experimental GLP-1 obesity drug TERN-601 showed a 5.5% reduction in…
FDA Approval for Sickle Cell Disease Gene-Therapy
In December 2023, the FDA approved two novel treatments for Sickle Cell…
Kipu Health acquires Hatch Compliance to expand behavioral health offerings
Kipu Health, a company specializing in technology solutions for behavioral health, has…
Live from Austin, Examining Health Equity
Julie Rovner is the chief Washington correspondent and host of KFF Health…
Plasma biomarkers help determine sports-related concussion neuropathology
New research conducted on adolescent Canadian athletes participating in high-risk contact sports…
With TV drug ads, what you see is not necessarily what you get
Drug ads on TV, social media, and the internet are prevalent, with…